共 5 条
Preimplantation genetic testing for aneuploidy is associated with reduced live birth rates in fresh but not frozen donor oocyte in vitro fertilization cycles: an analysis of 18,562 donor cycles reported to Society for Assisted Reproductive Technology Clinic Outcome Reporting System
被引:1
|作者:
Gingold, Julian A.
[1
,2
]
Kucherov, Alexander
[1
,2
,3
]
Wu, Haotian
[4
]
Fazzari, Melissa
[5
]
Lieman, Harry
[1
,2
]
Ball, G. David
[6
,7
]
Doody, Kevin
[8
]
Jindal, Sangita
[1
,2
]
机构:
[1] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Obstet & Gynecol & Womens Hlth, Bronx, NY USA
[2] Montefiores Inst Reprod Med & Hlth, Hartsdale, NY USA
[3] Illume Fertil, Norwalk, CT USA
[4] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA
[5] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY USA
[6] Seattle Reprod Med, Seattle, WA USA
[7] Reprod Med & Infertil Associates, Woodbury, MN USA
[8] CARE Fertil, Ctr Assisted Reprod, Bedford, TX USA
关键词:
Preimplantation genetic testing;
donor oocytes;
IVF outcomes;
national registry;
live birth rate;
D O I:
10.1016/j.fertnstert.2024.08.315
中图分类号:
R71 [妇产科学];
学科分类号:
100211 ;
摘要:
Objective: To evaluate the impact of preimplantation genetic testing for aneuploidy (PGT-A) on fi rst transfer live birth rate (LBR) and cumulative LBR (CLBR) in donor oocyte in vitro fertilization (IVF) cycles. Design: Retrospective cohort study of the Society for Assisted Reproductive Technology Clinic Outcome Reporting System database. Setting: Fertility centers reporting to Society for Assisted Reproductive Technology. Patient(s): A total of 11,348 fresh and 7,214 frozen-thawed donor oocyte IVF cycles were analyzed. Intervention(s): The fi rst reported donor stimulation cycle per patient between January 1, 2014, and December 31, 2015, and all linked embryo transfer cycles between January 1, 2014, and December 31, 2016, were included in the study. Main Outcome Measure(s): Live birth rate was compared for patients using fresh and frozen-thawed donor oocytes, with or without PGT-A. Logistic regression models were adjusted for age, body mass index, gravidity, infertility etiology, and prior IVF cycles. Result(s): Among patients who had blastocysts available for transfer or PGT-A, the use of PGT-A was associated with a decreased fi rst transfer LBR (46.9 vs. 53.2%) and CLBR (58.4 vs. 66.6%) in fresh oocyte donor cycles compared with no PGT-A. Live birth rate in frozen- thawed oocyte donor cycles with PGT-A were nominally higher than those without PGT-A (48.3% vs. 40.5%) but were not statistically significant in multivariable logistic regression models. Early pregnancy loss was not significantly different with and without PGT-A. Multiple gestation, preterm birth, and low birth weight infants were all reduced with the addition of PGT-A in fresh donor oocyte cycles, although these outcomes were not significantly different when comparing single embryo transfers in fresh oocyte cycles and also not significantly different among frozen-thawed donor oocyte cycles. Conclusion(s): Preimplantation genetic testing for aneuploidy in fresh oocyte donor cycles was associated with decreased LBR and CLBR, whereas effects on frozen-thawed oocyte donor cycles were clinically negligible. Obstetric benefits associated with PGT-A in fresh donor cycles appear linked to increased single embryo transfer. (Fertil Steril (R) 2025;123:50-60. (c) 2024 by American Society for Reproductive Medicine.)
引用
收藏
页码:50 / 60
页数:11
相关论文